BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35590333)

  • 1. A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China.
    Zhang RY; Wang W; Zhou HJ; Xuan JW; Luo N; Wang P
    Health Qual Life Outcomes; 2022 May; 20(1):80. PubMed ID: 35590333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the EQ-5D utilities are derived matters in Chinese diabetes patients: a comparison based on different EQ-5D scoring functions for China.
    Pan CW; Zhang RY; Luo N; He JY; Liu RJ; Ying XH; Wang P
    Qual Life Res; 2020 Nov; 29(11):3087-3094. PubMed ID: 32533422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Iran and UK EQ-5D-3L Value Sets Based on Visual Analogue Scale.
    Kiadaliri AA
    Int J Health Policy Manag; 2017 May; 6(5):267-272. PubMed ID: 28812814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
    Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
    Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
    Kiadaliri AA; Eliasson B; Gerdtham UG
    Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of EQ-5D-3L health utility scores using five country-specific tariffs in a rural population aged 45-69 years in Hua county, Henan province, China.
    Wang H; Cao C; Guo C; He Y; Li F; Xu R; Liu M; Liu Z; Pan Y; Liu F; Liu Y; Li J; Cai H; He Z; Ke Y
    Health Qual Life Outcomes; 2020 Jul; 18(1):228. PubMed ID: 32660494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.
    Janssen MF; Buchholz I; Golicki D; Bonsel GJ
    Pharmacoeconomics; 2022 Nov; 40(11):1081-1093. PubMed ID: 35930137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of four different approaches to measuring health utility in depressed patients.
    Turner N; Campbell J; Peters TJ; Wiles N; Hollinghurst S
    Health Qual Life Outcomes; 2013 May; 11():81. PubMed ID: 23659557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
    Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
    Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EuroQol-5D-3L and Short Form-6D Utility Scores in Family Caregivers of Colorectal Cancer Patients: A Cross-Sectional Survey in China.
    Sun CY; Liu Y; Zhou LR; Wang MS; Zhao XM; Huang WD; Liu GX; Zhang X
    Front Public Health; 2021; 9():742332. PubMed ID: 34660519
    [No Abstract]   [Full Text] [Related]  

  • 14. Population norms for the EQ-5D-3L in China derived from the 2013 National Health Services Survey.
    Yao Q; Liu C; Zhang Y; Xu L
    J Glob Health; 2021 Feb; 11():08001. PubMed ID: 33692898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J; Khan KA; Petrou S; Lamb SE
    Pharmacoeconomics; 2017 May; 35(5):549-559. PubMed ID: 28063083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
    Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
    BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.
    Nan Luo ; Johnson JA; Shaw JW; Coons SJ
    Med Decis Making; 2007; 27(3):321-6. PubMed ID: 17545501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.